Journal Home > Volume 7 , Issue 4
Journal of Neurorestoratology 2019, 7(4): 207-222 https://doi.org/10.26599/JNR.2019.9040026
Review Article | Open Access | Issue | Published: 17 January 2020

Traditional Chinese medicine-based neurorestorative therapy for Alzheimer’s and Parkinson’s disease

Show Author's Information Zhu Zhang1,2,§,  Shiqing Zhang1,2,§,  Cathy Nga-Ping Lui1,2,  Peili Zhu1,2,  Zhang Zhang1,2,  Kaili Lin1,2,  Yiwu Dai3( ),  Ken Kin-Lam Yung1,2( )
Department of Biology, Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong SAR, China
Golden Meditech Center for NeuroRegeneration Sciences (GMCNS), Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong SAR, China
Department of Neurosurgery, Bayi Brain Hospital, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, China

§ The authors contributed equally to this work

Keywords:
Parkinson’s disease, Alzheimer’s disease, traditional Chinese medicine, neurorestorative therapy
Cite this article:
Zhang Z, Zhang S, Lui CN-P, et al. Traditional Chinese medicine-based neurorestorative therapy for Alzheimer’s and Parkinson’s disease. Journal of Neurorestoratology, 2019, 7(4): 207-222. https://doi.org/10.26599/JNR.2019.9040026
Download citation
EndNote(RIS)
BibTeX

868

Views

58

Downloads

Citations

17

Crossref

15

WoS

0

Scopus

N/A

CSCD

Abstract Full text About this article

The prevalence of multiple neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), has been dramatically increasing, particularly in the aging population. However, the currently available therapies merely alleviate the symptoms of these diseases and are unable to retard disease progression significantly. Traditional Chinese medicine (TCM) has been used in clinical practice for thousands of years for ameliorating symptoms or interfering with the pathogenesis of aging- associated diseases. Modern pharmacological studies have proved that TCM imparts disease-modifying therapeutic effects against these diseases, such as protection of neurons, clearance of protein aggregates, and regulation of neuroinflammation. This review summarizes the evidence from recent studies on AD and PD therapies regarding the neuroprotective activities and molecular mechanisms of a series of TCM formulations comprising herbs and their active ingredients. The findings of this review support the use of TCM as an alternative source of therapy for the treatment of neurodegenerative diseases.


menu
Abstract
Full text
Outline
About this article

Traditional Chinese medicine-based neurorestorative therapy for Alzheimer’s and Parkinson’s disease

Show Author's information Zhu Zhang1,2,§, Shiqing Zhang1,2,§, Cathy Nga-Ping Lui1,2, Peili Zhu1,2, Zhang Zhang1,2, Kaili Lin1,2, Yiwu Dai3( ), Ken Kin-Lam Yung1,2( )
Department of Biology, Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong SAR, China
Golden Meditech Center for NeuroRegeneration Sciences (GMCNS), Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong SAR, China
Department of Neurosurgery, Bayi Brain Hospital, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, China

§ The authors contributed equally to this work

Abstract

The prevalence of multiple neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), has been dramatically increasing, particularly in the aging population. However, the currently available therapies merely alleviate the symptoms of these diseases and are unable to retard disease progression significantly. Traditional Chinese medicine (TCM) has been used in clinical practice for thousands of years for ameliorating symptoms or interfering with the pathogenesis of aging- associated diseases. Modern pharmacological studies have proved that TCM imparts disease-modifying therapeutic effects against these diseases, such as protection of neurons, clearance of protein aggregates, and regulation of neuroinflammation. This review summarizes the evidence from recent studies on AD and PD therapies regarding the neuroprotective activities and molecular mechanisms of a series of TCM formulations comprising herbs and their active ingredients. The findings of this review support the use of TCM as an alternative source of therapy for the treatment of neurodegenerative diseases.

Keywords: Parkinson’s disease, Alzheimer’s disease, traditional Chinese medicine, neurorestorative therapy

References(96)

[1]
E De Pablo-Fernández, AJ Lees, JL Holton, et al. Prognosis and neuropathologic correlation of clinical subtypes of parkinson disease. JAMA Neurol. 2019, 76(4): 470-479.
DOI Google Scholar
[2]
H Zetterberg, JM Schott. Biomarkers for Alzheimer's disease beyond amyloid and tau. Nat Med. 2019, 25(2): 201-203.
DOI Google Scholar
[3]
J Hardy, DJ Selkoe. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002, 297(5580): 353-356.
DOI Google Scholar
[4]
LM de Lau, MM Breteler. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006, 5(6): 525-535.
DOI Google Scholar
[5]
MG Spillantini, RA Crowther, R Jakes, et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett. 1998, 251(3): 205-208.
DOI Google Scholar
[6]
SI Finkel. Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer’s disease. Clin Ther. 2004, 26(7): 980-990.
DOI Google Scholar
[7]
JH Lee, SK Jeong, BC Kim, et al. Donepezil across the spectrum of Alzheimer’s disease: dose optimization and clinical relevance. Acta Neurol Scand. 2015, 131(5): 259-267.
DOI Google Scholar
[8]
MF Bastide, WG Meissner, B Picconi, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson’s disease. Prog Neurobiol. 2015, 132: 96-168.
DOI Google Scholar
[9]
U Bonuccelli, A Colzi, P Del Dotto. Pergolide in the treatment of patients with early and advanced Parkinson’s disease. Clin Neuropharmacol. 2002, 25(1): 1-10.
DOI Google Scholar
[10]
WD Le, J Jankovic. Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs Aging. 2001, 18(6): 389-396.
DOI Google Scholar
[11]
J Still. Use of animal products in traditional Chinese medicine: environmental impact and health hazards. Complement Ther Med. 2003, 11(2): 118-122.
DOI Google Scholar
[12]
TY Wu, CP Chen, CP Chen, et al. Traditional Chinese medicines and Alzheimer’s disease. Taiwan J Obstet Gynecol. 2011, 50(2): 131-135.
DOI Google Scholar
[13]
M Pallàs, D Porquet, A Vicente, et al. Resveratrol: new avenues for a natural compound in neuroprotection. Curr Pharm Des. 2013, 19(38): 6726-6731.
DOI Google Scholar
[14]
A Tachjian, V Maria, A Jahangir. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010, 55(6): 515-525.
DOI Google Scholar
[15]
AL Hopkins. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008, 4(11): 682-690.
DOI Google Scholar
[16]
I Solanki, P Parihar, MS Parihar. Neurodegenerative diseases: From available treatments to prospective herbal therapy. Neurochem Int. 2016, 95: 100-108.
DOI Google Scholar
[17]
SY Gao, JW Lin, TQ Wang, et al. Qingxin Kaiqiao Fang ameliorates memory impairment and inhibits apoptosis in APP/PS1 double transgenic mice through the MAPK pathway. Drug Des Devel Ther. 2019, 13: 459-475.
DOI Google Scholar
[18]
GW Gong, BH Qi, YT Liang, et al. Danggui Buxue Tang, an ancient Chinese herbal decoction, protects β-amyloid-induced cell death in cultured cortical neurons. BMC Complement Altern Med. 2019, 19(1): 9.
DOI Google Scholar
[19]
R Shi, SS Zhang, GQ Cheng, et al. Ginsenoside Rg1 and acori graminei rhizoma attenuates neuron cell apoptosis by promoting the expression of miR-873-5p in Alzheimer’s disease. Neurochem Res. 2018, 43(8): 1529-1538.
DOI Google Scholar
[20]
YS Mo, EJ Xu, RR Wei, et al. Bushen-yizhi formula alleviates neuroinflammation via inhibiting NLRP3 inflammasome activation in a mouse model of Parkinson’s disease. Evid Based Complement Alternat Med. 2018, 2018: 3571604.
DOI Google Scholar
[21]
RR Wei, J OuYang, WX Lin, et al. Curative anti- inflammatory properties of Chinese optimized yinxieling formula in models of Parkinson's disease. Evid Based Complement Alternat Med. 2018, 2018: 6142065.
DOI Google Scholar
[22]
XX Bao, HH Ma, H Ding, et al. Preliminary optimization of a Chinese herbal medicine formula based on the neuroprotective effects in a rat model of rotenone-induced Parkinson’s disease. J Integr Med. 2018, 16(4): 290-296.
DOI Google Scholar
[23]
ZG Li, KYC Lam, XY Liu, et al. A Chinese herbal preparation, Xiao-Er-An-Shen decoction, exerts neuron protection by modulation of differentiation and antioxidant activity in cultured PC12 cells. Evid Based Complement Alternat Med. 2018, 2018: 8670421.
DOI Google Scholar
[24]
L Yan, M Wei, AG Gong, et al. A modified Chinese herbal decoction (Kai-Xin-San) promotes NGF-induced neuronal differentiation in PC12 cells via up-regulating trk A signaling. Front Cell Dev Biol. 2017, 5: 118.
DOI Google Scholar
[25]
IC Chen, TH Lin, YH Hsieh, et al. Formulated Chinese medicine Shaoyao Gancao Tang reduces tau aggregation and exerts neuroprotection through anti-oxidation and anti-inflammation. Oxid Med Cell Longev. 2018, 2018: 9595741.
DOI Google Scholar
[26]
C Cao, JY Xiao, MQ Liu, et al. Active components, derived from Kai-Xin-San, a herbal formula, increase the expressions of neurotrophic factor NGF and BDNF on mouse astrocyte primary cultures via cAMP- dependent signaling pathway. J Ethnopharmacol. 2018, 224: 554-562.
DOI Google Scholar
[27]
CY Zhu, QH Xu, ZY Mao, et al. The Chinese medicine Wu-Tou decoction relieves neuropathic pain by inhibiting hippocampal microglia activation. Sci Rep. 2018, 8(1): 12292.
DOI Google Scholar
[28]
BS He, FX Xu, TX Yan, et al. Tectochrysin from Alpinia Oxyphylla Miq. alleviates Aβ1-42 induced learning and memory impairments in mice. Eur J Pharmacol. 2019, 842: 365-372.
DOI Google Scholar
[29]
Y Qi, XH Cheng, HT Jing, et al. Effect of Alpinia oxyphylla-Schisandra chinensis herb pair on inflammation and apoptosis in Alzheimer’s disease mice model. J Ethnopharmacol. 2019, 237: 28-38.
DOI Google Scholar
[30]
YL Wang, MS Wang, KY Fan, et al. Protective effects of Alpinae Oxyphyllae Fructus extracts on lipopolysaccharide-induced animal model of Alzheimer’s disease. J Ethnopharmacol. 2018, 217: 98-106.
DOI Google Scholar
[31]
YL Wang, MS Wang, MJ Xu, et al. Nootkatone, a neuroprotective agent from Alpiniae Oxyphyllae Fructus, improves cognitive impairment in lipopolysaccharide- induced mouse model of Alzheimer’s disease. Int Immunopharmacol. 2018, 62: 77-85.
DOI Google Scholar
[32]
BS He, FX Xu, F Xiao, et al. Neuroprotective effects of nootkatone from Alpiniae oxyphyllae Fructus against amyloid-β-induced cognitive impairment. Metab Brain Dis. 2018, 33(1): 251-259.
DOI Google Scholar
[33]
L Zhou, PP Huang, LL Chen, et al. Panax notoginseng saponins ameliorate Aβ-mediated neurotoxicity in C. Elegans through antioxidant activities. Evid Based Complement Alternat Med. 2019, 2019: 7621043.
DOI Google Scholar
[34]
SZ Liu, W Cheng, JW Shao, et al. Notoginseng saponin Rg1 prevents cognitive impairment through modulating APP processing in Aβ1-42-injected rats. Curr Med Sci. 2019, 39(2): 196-203.
DOI Google Scholar
[35]
BB Zhang, XL Hu, YY Wang, et al. Neuroprotective effects of dammarane-type saponins from Panax notoginseng on glutamate-induced cell damage in PC12 cells. Planta Med. 2019, 85(9/10): 692-700
DOI Google Scholar
[36]
JL Huang, YQ Feng, LR Bai, et al. Fraction n-butanol of Radix notoginseng protects PC12 cells from Aβ25-35- induced cytotoxicity and alleviates cognitive deficits in SAMP8 mice by attenuating oxidative stress and Aβ accumulation. Evid Based Complement Alternat Med. 2017, 2017: 8469754.
DOI Google Scholar
[37]
Y Zhang, ZF Pi, FR Song, et al. Ginsenosides attenuate d-galactose- and AlCl3-inducedspatial memory impairment by restoring the dysfunction of the neurotransmitter systems in the rat model of Alzheimer’s disease. J Ethnopharmacol. 2016, 194: 188-195.
DOI Google Scholar
[38]
EJ Kim, IH Jung, TK van Le, et al. Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice. J Ethnopharmacol. 2013, 146(1): 294-299.
DOI Google Scholar
[39]
HM Luo, JT Hu, Y Wang, et al. In vivo and in vitro neuroprotective effects of Panax ginseng glycoproteins. Int J Biol Macromol. 2018, 113: 607-615.
DOI Google Scholar
[40]
YM Pan, JQ Xu, P Jin, et al. Royal jelly ameliorates behavioral deficits, cholinergic system deficiency, and autonomic nervous dysfunction in ovariectomized cholesterol-fed rabbits. Molecules. 2019, 24(6): E1149.
DOI Google Scholar
[41]
YM Pan, JQ Xu, C Chen, et al. Royal jelly reduces cholesterol levels, ameliorates Aβ pathology and enhances neuronal metabolic activities in a rabbit model of Alzheimer’s disease. Front Aging Neurosci. 2018, 10: 50.
DOI Google Scholar
[42]
XX Zhang, X Wang, XH Hu, et al. Neuroprotective effects of a Rhodiola crenulata extract on amyloid-β peptides (Aβ1-42)-induced cognitive deficits in rat models of Alzheimer's disease. Phytomedicine. 2019, 57: 331-338.
DOI Google Scholar
[43]
H Tang, J Wang, L Zhao, et al. Rhodiola rosea L extract shows protective activity against Alzheimer’s disease in 3xTg-AD mice. Trop J Pharm Res. 2017, 16(3): 509.
DOI Google Scholar
[44]
JM Wang, ZQ Qu, JL Wu, et al. Mitochondrial protective and anti-apoptotic effects of Rhodiola crenulata extract on hippocampal neurons in a rat model of Alzheimer’s disease. Neural Regen Res. 2017, 12(12): 2025-2034.
DOI Google Scholar
[45]
SC Huang, JX Mao, K Ding, et al. Polysaccharides from Ganoderma lucidum promote cognitive function and neural progenitor proliferation in mouse model of Alzheimer’s disease. Stem Cell Reports. 2017, 8(1): 84-94.
DOI Google Scholar
[46]
GX Lai, YR Guo, DL Chen, et al. Alcohol extracts from Ganoderma lucidum delay the progress of Alzheimer’s disease by regulating DNA methylation in rodents. Front Pharmacol. 2019, 10: 272.
DOI Google Scholar
[47]
QX Xu, Y Hu, GY Li, et al. Multi-target anti-alzheimer activities of four prenylated compounds from Psoralea fructus. Molecules. 2018, 23(3): E614.
DOI Google Scholar
[48]
ZJ Chen, YF Yang, YT Zhang, et al. Dietary total prenylflavonoids from the fruits of Psoralea corylifolia L. prevents age-related cognitive deficits and down- regulates Alzheimer’s markers in SAMP8 mice. Molecules. 2018, 23(1): E196.
DOI Google Scholar
[49]
YJ Chiu, CM Lee, TH Lin, et al. Chinese herbal medicine Glycyrrhiza inflata reduces Aβ aggregation and exerts neuroprotection through anti-oxidation and anti-inflammation. Am J Chin Med. 2018, 46(7): 1535-1559.
DOI Google Scholar
[50]
YH Ko, SH Kwon, SY Lee, et al. Liquiritigenin ameliorates memory and cognitive impairment through cholinergic and BDNF pathways in the mouse Hippocampus. Arch Pharm Res. 2017, 40(10): 1209-1217.
DOI Google Scholar
[51]
PJ Xu, ZG Li, H Wang, et al. Triptolide inhibited cytotoxicity of differentiated PC12 cells induced by amyloid-beta₂₅₋₃₅ via the autophagy pathway. PLoS One. 2015, 10(11): e0142719.
DOI Google Scholar
[52]
CQ Ning, LM Mo, XW Chen, et al. Triptolide derivatives as potential multifunctional anti-Alzheimer agents: Synthesis and structure-activity relationship studies. Bioorg Med Chem Lett. 2018, 28(4): 689-693.
DOI Google Scholar
[53]
K Veerappan, S Natarajan, P Ethiraj, et al. Inhibition of IKKβ by celastrol and its analogues-an in silico and in vitro approach. Pharm Biol. 2017, 55(1): 368-373.
DOI Google Scholar
[54]
YR Qin, Y Zhang, I Tomic, et al. Ginkgo biloba extract EGb 761 and its specific components elicit protective protein clearance through the autophagy-lysosomal pathway in tau-transgenic mice and cultured neurons. J Alzheimers Dis. 2018, 65(1): 243-263.
DOI Google Scholar
[55]
C Huang, FQ Lin, GQ Wang, et al. Tetrahydroxystilbene glucoside produces neuroprotection against 6-OHDA- induced dopamine neurotoxicity. Oxidative Med Cell Longev. 2018, 2018: 1-9.
DOI Google Scholar
[56]
YD Zhu, J Zhu, X Yang, et al. Polygonum multiflorum extracts protect the SH-SY5Y cells against the oxidative stress injury induced by MPP+. Int J Neurorehabilitation Eng. 2016, 3(5): 2376-0281.
DOI Google Scholar
[57]
C Yang, YS Mo, EJ Xu, et al. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model. Int Immunopharmacol. 2019, 75: 105651.
DOI Google Scholar
[58]
H Gao, LR Dou, L Shan, et al. Proliferation and committed differentiation into dopamine neurons of neural stem cells induced by the active ingredients of Radix astragali. Neuroreport. 2018, 29(7): 577-582.
DOI Google Scholar
[59]
H Liu, S Chen, CJ Guo, et al. Astragalus polysaccharide protects neurons and stabilizes mitochondrial in a mouse model of parkinson disease. Med Sci Monit. 2018, 24: 5192-5199.
DOI Google Scholar
[60]
S Peng, L Xu, JY Ma, et al. Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis induced by rotenone and 6-hydroxydopamine. Neural Regen Res. 2018, 13(11): 1981-1987.
DOI Google Scholar
[61]
MZ Zheng, CM Liu, YJ Fan, et al. Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental Parkinsonism by regulating the cAMP/ PKA/CREB signaling pathway. J Ethnopharmacol. 2019, 245: 112182.
DOI Google Scholar
[62]
TT Zhou, MR Zhu, ZH Liang. (-)-Epigallocatechin- 3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease. Mol Med Rep. 2018, 17(4): 4883-4888.
DOI Google Scholar
[63]
SM Liu, XZ Li, SN Zhang, et al. Acanthopanax senticosus protects structure and function of mesencephalic mitochondria in a mouse model of Parkinson’s disease. Chin J Integr Med. 2018, 24(11): 835-843.
DOI Google Scholar
[64]
ZL Ren, CD Wang, T Wang, et al. Ganoderma lucidum extract ameliorates MPTP-induced Parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Acta Pharmacol Sin. 2019, 40(4): 441-450.
DOI Google Scholar
[65]
MY Liao, YD Zhao, LZ Huang, et al. Isoliquiritigenin and liquiritin from Glycyrrhiza uralensis inhibit α-synuclein amyloid formation. RSC Adv. 2016, 6(89): 86640-86649.
DOI Google Scholar
[66]
GZ Hu, XL Gong, L Wang, et al. Triptolide promotes the clearance of α-synuclein by enhancing autophagy in neuronal cells. Mol Neurobiol. 2017, 54(3): 2361-2372.
DOI Google Scholar
[67]
AM Gorman. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med. 2008, 12(6A): 2263-2280.
DOI Google Scholar
[68]
SG Cho, EJ Choi. Apoptotic signaling pathways: caspases and stress-activated protein kinases. J Biochem Mol Biol. 2002, 35(1): 24-27.
DOI Google Scholar
[69]
WW Wong, H Puthalakath. Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. IUBMB Life. 2008, 60(6): 390-397.
DOI Google Scholar
[70]
SQ Feng, J Xiao, FB Han, et al. Neurorestorative clinical application standards for the culture and quality control of neural progenitor/precursor cells (version 2017). J Neurorestoratol. 2018, 6: 65-68.
DOI Google Scholar
[71]
S Pinton, T Sampaio, A Savall, et al. Neurotrophic factors in Alzheimer’s and Parkinson’s diseases: implications for pathogenesis and therapy. Neural Regen Res. 2017, 12(4): 549.
DOI Google Scholar
[72]
T Zigova, V Pencea, SJ Wiegand, et al. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol Cell Neurosci. 1998, 11(4): 234-245.
DOI Google Scholar
[73]
T Kobayashi, H Ahlenius, P Thored, et al. Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke. 2006, 37(9): 2361-2367.
DOI Google Scholar
[74]
A Ghosh, ME Greenberg. Distinct roles for bFGF and NT-3 in the regulation of cortical neurogenesis. Neuron. 1995, 15(1): 89-103.
DOI Google Scholar
[75]
G Acsadi, RA Anguelov, HB Yang, et al. Increased survival and function of SOD1 mice after glial cell- derived neurotrophic factor gene therapy. Hum Gene Ther. 2002, 13(9): 1047-1059.
DOI Google Scholar
[76]
LF Kromer. Nerve growth factor treatment after brain injury prevents neuronal death. Science. 1987, 235(4785): 214-216.
DOI Google Scholar
[77]
W Fischer, K Wictorin, A Björklund, et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 1987, 329(6134): 65-68.
DOI Google Scholar
[78]
KYC Lam, QY Wu, WH Hu, et al. Asarones from Acori Tatarinowii Rhizoma stimulate expression and secretion of neurotrophic factors in cultured astrocytes. Neurosci Lett. 2019, 707: 134308.
DOI Google Scholar
[79]
CK Glass, K Saijo, B Winner, et al. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010, 140(6): 918-934.
DOI Google Scholar
[80]
T Nagatsu, M Sawada. Inflammatory process in Parkinson’s disease: role for cytokines. Curr Pharm Des. 2005, 11(8): 999-1016.
DOI Google Scholar
[81]
I Russo, S Barlati, F Bosetti. Effects of neuroinflammation on the regenerative capacity of brain stem cells. J Neurochem. 2011, 116(6): 947-956.
DOI Google Scholar
[82]
HM Gao, JS Hong. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 2008, 29(8): 357-365.
DOI Google Scholar
[83]
RK Sajja, MA Kaisar, V Vijay, et al. In vitro modulation of redox and metabolism interplay at the brain vascular endothelium: genomic and proteomic profiles of sulforaphane activity. Sci Rep. 2018, 8(1): 12708.
DOI Google Scholar
[84]
I Buendia, P Michalska, E Navarro, et al. Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther. 2016, 157: 84-104.
DOI Google Scholar
[85]
E Chernykh, E Shevela, M Kafanova, et al. Monocyte- derived macrophages for treatment of cerebral palsy: a study of 57 cases. J Neurorestoratol. 2018, 6: 41-47.
DOI Google Scholar
[86]
KYC Lam, P Yao, HY Wang, et al. Asarone from Acori Tatarinowii Rhizome prevents oxidative stress- induced cell injury in cultured astrocytes: a signaling triggered by Akt activation. PLoS One. 2017, 12(6): e0179077.
DOI Google Scholar
[87]
B Gargouri, J Carstensen, HS Bhatia, et al. Anti- neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells. Phytomedicine. 2018, 44: 45-55.
DOI Google Scholar
[88]
Q Cai, YY Li, G Pei. Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response. J Neuroinflammation. 2017, 14(1): 63.
DOI Google Scholar
[89]
SY Park, ML Jin, NJ Kang, et al. Anti-inflammatory effects of novel Polygonum multiflorum compound via inhibiting NF-κB/MAPK and upregulating the Nrf2 pathways in LPS-stimulated microglia. Neurosci Lett. 2017, 651: 43-51.
DOI Google Scholar
[90]
MY Huang, CE Tu, SC Wang, et al. Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia. BMC Complement Altern Med. 2018, 18(1): 221.
DOI Google Scholar
[91]
MM You, YF Chen, YM Pan, et al. Royal jelly attenuates LPS-induced inflammation in BV-2 microglial cells through modulating NF-κB and p38/JNK signaling pathways. Mediators Inflamm. 2018, 2018: 7834381.
DOI Google Scholar
[92]
CA Ross, MA Poirier. Opinion: What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol. 2005, 6(11): 891-898.
DOI Google Scholar
[93]
AB Singleton, M Farrer, J Johnson, et al. Alpha- Synuclein locus triplication causes Parkinson's disease. Science. 2003, 302(5646): 841.
DOI Google Scholar
[94]
JA Hardy, GA Higgins. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992, 256(5054): 184-185.
DOI Google Scholar
[95]
M Komatsu, S Waguri, T Chiba, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006, 441(7095): 880-884.
DOI Google Scholar
[96]
T Hara, K Nakamura, M Matsui, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006, 441(7095): 885-889.
DOI Google Scholar
Publication history
Copyright
Rights and permissions

Publication history

Received: 21 October 2019
Revised: 03 December 2019
Accepted: 30 December 2019
Published: 17 January 2020
Issue date: December 2019

Copyright

© The authors 2019

Rights and permissions

This article is published with open access at http://jnr.tsinghuajournals.com

Return